Title : Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial - Piette_2011_Alzheimers.Res.Ther_3_16 |
Author(s) : Piette F , Belmin J , Vincent H , Schmidt N , Pariel S , Verny M , Marquis C , Mely J , Hugonot-Diener L , Kinet JP , Dubreuil P , Moussy A , Hermine O |
Ref : Alzheimers Res Ther , 3 :16 , 2011 |
Abstract : Piette_2011_Alzheimers.Res.Ther_3_16 |
ESTHER : Piette_2011_Alzheimers.Res.Ther_3_16 |
PubMedSearch : Piette_2011_Alzheimers.Res.Ther_3_16 |
PubMedID: 21504563 |
Piette F, Belmin J, Vincent H, Schmidt N, Pariel S, Verny M, Marquis C, Mely J, Hugonot-Diener L, Kinet JP, Dubreuil P, Moussy A, Hermine O (2011)
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
Alzheimers Res Ther
3 :16
Piette F, Belmin J, Vincent H, Schmidt N, Pariel S, Verny M, Marquis C, Mely J, Hugonot-Diener L, Kinet JP, Dubreuil P, Moussy A, Hermine O (2011)
Alzheimers Res Ther
3 :16